Epidermal thinning: Evaluation of commercial corticosteroids

Asboe-Hansen, G., Brodthagen H. Zachariae, L.: Treatment of keloids with topical injections of hydrocortisone acetate. Arch. Dermatol. 73, 162–165 (1956) Alexander, S., Lyne, C.: A preliminary clinical trial of hydrocortisone-17-butyrate. Br. J. Clin. Pract. 27, 177–179 (1973) Allenby, C. F., Main, R. A., Marsdenc, R. A., Sparkes, C. G.: Effect on adrenal function of topically applied clobetasol propionate (Dermovate). Br. Med. J. 4, 619–621 (1975) Allison, A. C.: Effects of glucocorticosteroids on lymphocytes and macrophages. Clin. Exp. Dermatol. 4, 135–138 (1979) Baker, B. L., Whitaker, W. L.: Growth inhibition in the skin following direct application of adrenal cortical preparations. Anat. Rec. 102, 333–347 (1948) Baker, B. L., Ingle, D. J., Li, C. H., Evans, H. M.: Growth inhibition in the skin induced by parenteral administration of adrenocorticotropin. Anat. Rec. 102, 313–331 (1948) Baker, H., Sattar, H. A.: The assessment of four new fluocortolone analogues by a modified vasoconstriction assay. Br. J. Dermatol. 80, 46–53 (1968) Baker, J. R. J., Christian, R. A., Simpson, P., White, A. M.: The binding of topically applied glucocorticoids to rat skin. Br. J. Dermatol. 96, 171–178 (1977) Barry, B. W., Woodford, R.: Comparitive bio-availability of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty creams and gels. Br. J. Dermatol. 91, 323–338 (1974) Barry, B. W., Woodford, R.: Comparitive bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments. Br. J. Dermatol. 93, 563–571 (1975) Barry, B. W., Woodford, R.: Vasoconstrictor activities and bio-availabilities of 7 proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications. Br. J. Dermatol. 97, 555–560 (1977) Belman, S., Troll, W.: Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3′,5′-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline. Cancer Res. 34, 3446–3455 (1974) Belšan, I., Neumann, E., Blažková, B.: Kinetics of glycolysis after fluocinolone acetonide in psoriasis. Acta Derm.-Venereol. 45, 297–301 (1965) Berliner, D. L., Bartley, M. H., Kenner, G. H., Jee, W. S. S.: Activity of anti-inflammatory steroi upon fibroblasts and bones. Br. J. Dermatol. 82, Supplement 6, 53–61 (1970) Björnberg, A., Hellgren, L.: Treatment of psoriasis with clobetasol propionate: a double-blind comparison with betamethasone valerate. Curr. Med. Res. Opinion, 3, 36–38 (1975) Braun-Falco, O., Thianprasit, M., Kint, A.: Über den Einfluß einer lokalen Okklusiv-Therapie mit Fluorandrenolon auf die psoriatische Hautreaktion. Eine histologische-histochemische Studie. Arch. Klin. Exp. Dermatol. 217, 30–49 (1963) Briggs, M. H., Briggs, M.: Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons. Br. J. Dermatol. 88, 75–81 (1973) Brotherton, J.: Parallel-line biological assay of anti-inflammatory steroids using skin fibroblasts. Cytobios. 3, 225–238 (1971) Bullough, W. S.: Mitotic and functional homeostasis. A speculative review. Cancer Res. 25, 1683–1727 (1965) Burton, J. L.: In discussion following Winter and Burton (1976) Carruthers, J. A., August, P. J., Staughton, R. C. D.: Observations on the systemic effect of topical clobetasol propionate (Dermovate) Br. Med. J. 4, 203–204 (1975) Castor, C. W., Baker, B. L.: The local action of adrenocortical steroids on epidermis and connective tissue of the skin. Endocrinology 47, 234–241 (1950) Christophers, E.: Die Wanderungskinetik postmitotischer Epidermiszellen. Autoradiographische Untersuchungen. Arch. Klin. Exp. Dermatol. 236, 161–172 (1970) Coldman, M. F., Lockerbie, L.: Placebo ointment response in the blanching test. Br. J. Dermatol. 85, 398–400 (1971) Coldman, M. F., Lockerbie, L., Laws, E. A.: The evaluation of several topical corticosteroid preparations in the blanching test. Br. J. Dermatol. 85, 381–387 (1971) Coldman, M. F., Lockerbie, L., Laws, E. A.: The evaluation of a novel corticosteroid formulation, fluocinonide in “FAPG” base, in the blanching test. Br. J. Dermatol. 85, 573–576 (1971a) Corbett, M. F.: The response of psoriasis to betamethasone valerate and topical clobetasol propionate. Br. J. Dermatol. 94, Suppl 12, 89–93 (1976) Cronin, E., Stoughton, R. B.: Percutaneous absorption: regional variations and the effect of hydration and epidermal stripping. Br. J. Dermatol. 74, 265–272 (1972) Cruickshank, C. N. D.: In discussion following Kirby and Munro (1976) Cunningham, D. D., Thrash, C. R., Glynn, R. D.: Initiation of division of density-inhibited fibroblasts by glucocorticoids. In: Control of proliferation in animal cells. Cold Spring Harbour Conferences on Cell Proliferation. Clarkson, B., Baserga, R. (eds.), Vol. 1, pp. 105–113. Cold Spring Harbour Lab. 1974 Delforno, C., Holt, P. J. A., Marks, R.: Corticosteroid effect on epidermal cell size. Br. J. Dermatol. 98, 619–623 (1978) Dumas, K. J., Scholtz, J. R.: The psoriasis bio-assay for topical corticosteroid activity. Acta Derm.-Venereol. 52, 43–48 (1972) Du Vivier, A.: Tachyphylaxis to topically applied steroids. Arch. Dermatol. 112, 1245–1248 (1976) Du Vivier, A.: Stoughton, R. B.: Tachyphylaxis to the action of topically applied corticosteroids. Arch. Dermatol. 111, 581–583 (1975) Du Vivier, A., Marshall, R. C., Brookes, L. G.: An animal model for evaluating the local and systemic effects of topically applied corticosteroids on epidermal DNA synthesis. Br. J. Dermatol. 98, 209–215 (1978) Dykes, P. J., Marks, R.: Measurement of skin thickness: A comparison of two in vivo techniques with a conventional histometric method. J. Invest. Dermatol. 69, 275–278 (1977) Dykes, P. J., Steroid structure and steroid activity. Br. J. Dermatol. 94, Suppl. 12, 3–13 (1976) Falconi, G., Rossi, G. L.: Paper-patch test for evaluating vasoconstrictive activity of corticosteroids. Arch. Dermatol. 105, 856–858 (1972) Feinblatt, B. I., Aceto, T., Jr., Beckhorn, G., Bruck, E.: Percutaneous absorption of hydrocortisone in children. Am. J. Dis. Child., 112, 218–224 (1966) Feldman, R. J., Maibach, H. I.: Regional variation in percutaneous penetration of 14C Cortisol in man. J. Invest. Dermatol. 48, 181–183 (1967) Fell, H. B.: The experimental study of keratinization in organ culture. In: The epidermis, Montagna, W., Lobitz, W. C. Jr. (eds.), Chap. IV, pp. 61–81. New York: Acad. Press 1964 Fisher, A. A.: Immediate and delayed allergic contact reactions to polyethylene glycol. Contact Dermatitis 4, 135–138 (1978) Greaves, M. S.: The in vivo catabolism of cortisol by human skin. J. Invest Dermatol. 57, 100–107 (1971) Hall, D. A., Reed, F. B., Nuki, G., Vince, J. D.: The relative effects of age and corticosteroid therapy on the collagen profiles of dermis from subjects with rheumatoid arthritis. Age Ageing 3, 15–22 (1974) Harvey, W., Grahame, R., Panayi, G. S.: Effects of steroid hormones on human fibroblasts in vitro. I. Glucocorticoid action on cell growth and collagen synthesis. Ann. Rheum. Dis. 33, 437–441 (1974) Haynes, R. C., Jr.: Biochemical mechanisms of steroid effects. In: Steroid therapy, Azarnoff, D. L. (ed.), pp. 15–26. Toronto: W. B. Saunders 1975 Hendrikse, J. C. M., Moolenaar, A. J.: Adrenal suppression with topical hydrocortisone butyrate. Dermatologica 147, 191–197 (1973) Jarrett, A.: The physiology and pathophysiology of the skin: The Epidermis, Vol 1. London: Acad. Press 1973 Jarrett, A., Spearman, R. I. C.: Histochemistry of the skin-psoriasis. Eng. Univ. Press 1964 Jimenez de Asua, L. J., Carr, B., Clingan, D., Rudland, P. S.: Specific glucocorticoid inhibition of growth promoting effects of prostaglandin F2 α on 3T3 cells. Nature 265, 450–452 (1977) Johns, A. M., Bower, B. D.: Wasting of napkin area after repeated use of fluorinated steroid ointment. Br. Med. J. 1, 347–348 (1970) Kirby, J. D., Munro, D. D.: Steroid-induced atrophy in an animal and human model. Br. J. Dermatol. 94, Suppl. 12, 111–119 (1976) Kirk, D., Mittwoch, U.: Effects, of topically potent glucocorticoids on human diploid fibroblasts in vitro. Br. J. Dermatol. 97, 69–75 (1977) Keipert, J. A., Kelly, R.: Temporary Cushing's Syndrome from percutaneous absorption of betamethasone 17-valerate. Med. J. Australia, 1, 542–544 (1971) Laurence, E. B., Christophers, E.: Selective action of hydrocortisone on postmitotic epidermal cells in vivo. J. Invest. Dermatol. 66, 222–229 (1976) Livingood, C. S., Hildebrand, J. F., Key, J. S., Smith, R. W., Jr.: Studies on the percutaneous absorption of fluorocortisone. Arch. Dermatol. 72, 313–327 (1955) Lowe, N., Stoughton, R. B.: Essential fatty acid deficient hairless mouse: A model of chronic epidermal hyperproliferation. Br. J. Dermatol. 96, 155–162 (1977) Lukacs, I., Braun-Falco, O.: Zur Wirkungsweise von Glucocorticosteroiden in der Epidermis. Arch. Dermatol. Forsch. 243, 326–334 (1972). Marks, R.: Methods for the assessment of skin atrophogenicity of topical corticosteroids. Dermatologica 152, Suppl. 1, 117–126 (1976) Marks, R., Pongsehirun, D., Saylan, T.: A method for the assay of topical corticosteroids. Br. J. Dermatol. 88, 69–74 (1973) Marks, R., Halprin, K., Fukui, K., Graff, D.: Topically applied triamcinolone and macromolecular synthesis by human epidermis. J. Invest. Dermatol. 56, 470–473 (1971) Marshall, R. C., Du Vivier, A.: The effects on epidermal DNA synthesis of the butyrate esters of clobetasone and clobetasol, and the propionate ester of clobetasol. Br. J. Dermatol. 98, 355–359 (1978) McKenzie, A. W., Stoughton, R. B.: Method for comparing percutaneous absorption of steroids. Arch. Dermatol. 86, 608–610 (1962) Moon, H. D.: Inhibition of somatic growth in castrate rats with pituitary extracts. Proc. Soc. Exp. Biol. Med. 37, 34–36 (1937) Moore-Robinson, M., Christie, G. A.: Vasoconstrictor activity of topical corticosteroids-methodology and results. Br. J. Dermatol. 82, Suppl. 6, 86–92 (1970) Morley, N., Fry, L., Walker, S.: Clinical evaluation of clobetasone butyrate in the treatment of children with atopic eczema, and its effect on plasma corticosteroid levels. Curr. Med. Res. Opinion 4, 223–228 (1976) Munro, D. D.: In discussion following Kirby and Munro (1976) Munro, D. D., Wilson, L.: Clobetasone butyrate, a new topical corticosteroid: Clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. Br. Med. J. 3, 626–628 (1975) Place, V. A., Velazquez, J. G., Burdick, K. H.: Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay. Arch. Dermatol. 101, 531–537 (1970) Polano, M. K., Kanaar, P.: A clinical trial with hydrocortisone butyrate cream in eczema. Br. J. Derm. 88, 83–85 (1973) Polano, M. K., Suurmond, D., Lely, M. A. v. d., Warnaar, P. A.: Clinical trial with hydrocortisone butyrate cream in psoriasis. Br. J. Dermatol. 83, 93–97 (1970) Portnoy, B., Sarkany, I.: “Metosyn” in psoriasis and eczema. Br. J. Dermatol. 86, 310–311 (1972) Rasche, B., Ulmer, W. T.: Über die Wirkung der Glucocorticoide und der Mineralocorticoide auf Stoffwechsel und Wachstum von Zellen mesenchymalen sowie epithelialen Ursprungs, Z. Ges. Exp. Med. 152, 42–55 (1970) Reaven, E. P., Cox, A. J.: Behavior of adult human skin in organ culture. J. Invest. Dermatol. 50, 118–128 (1968) Rudland, P. S., Seifert, W., Gospodarowicz, D.: Growth control in cultured mouse fibroblasts: Induction of the pleiotypic and mitogenic response by a purified growth factor. Proc. Natl. Acad. Sci. 71, 2600–2604 (1974) Runkis, J. O., McLean, D. I., Stewart, W. D.: Growth rate of cultured human fibroblasts increased by glucocorticoids. J. Invest. Dermatol. 70, 348–351 (1978) Rutherford, T., Pawlowski, A.: Acid phosphatase staining of the stratum corneum as a marker of damage by low irritancy compounds. Br. J. Dermatol. 91, 503–506 (1974) Saarni, H., Hopsu-Havu, V. K.: Effect of hydrocortisone butyrate on collagen synthesis. Br. J. Dermatol. 95, 566–567 (1976) Saarni, H., Hopsu-Havu, V. K.: The decrease in hyaluronate synthesis by anti-inflammatory steroids in vitro. Br. J. Dermatol. 98, 445–449 (1978) Sarkany, I., Gaylarde, P. M.: Thickening of guinea pig epidermis due to application of commonly used ointment bases. Trans. St. Johns Hosp. Dermatol. Soc. 59, 241–243 (1973) Schöpf, E.: Side effects from topical corticosteroid therapy. Annals Clin. Res. 7, 353–367 (1975) Sim, A. W., Picton, W., Fox, P. K., Walker, G. B.: The effect of topical corticosteroids on the metabolism of dermal collagen. In: Mechanisms of topical corticosteroid activity, Wilson, L. C., Marks, R. (eds.), Chap. 11, pp. 89–96. London: Churchill Livingstone 1976 Snell, E. S.: Pharmacological properties of corticosteroids in relation to clinical efficacy. Br. J. Dermatol. 94, Suppl. 12, 15–23 (1976) Sparkes, C. G.: Measuring adrenal function in out-patients using topical corticosteroids. Br. J. Dermatol. 94, Suppl. 12, 77–82 (1976) Sparkes, C. G., Wilson, L.: The clinical evaluation of a new topical corticosteroid, clobetasol propionate. An international controlled trial. Br. J. Dermatol. 90, 197–203 (1974) Spearman, R. I. C.: The evolution of mammalian keratinized structures. In: The mammalian epidermis and its derivatives. Symp. Zool. Soc. (Lond.) No. 12, 67–81 (1964) Spearman, R. I. C.: Intrinsic and extrinsic factors in epidermal modulation. In: The skin of vertebrates, Spearman, R. I. C., Riley, P. A. (eds.), Symp. Linnean Soc. (Lond.). London: Acad. Press (In press) Spearman, R. I. C., Hardy, J. A.: Ultrastructure of the contrasting types of keratinization seen in the tail epidermis of the laboratory mouse Mus musculus. Arch. Dermatol. Res. 258, 33–40 (1977) Spearman, R. I. C., Jarrett, A.: Bio-assay of corticosteroids for topical application. Br. J. Dermatol. 92, 581–584 (1975) Spearman, R. I. C., Jarrett, A.: The mouse tail test for evaluation of topically applied corticosteroids. Int. J. Dermatol. 15, 515–516 (1976) Staughton, R. C. D., August, P.: Cushing's Syndrome and pituitary-adrenal suppression due to clobetasol propionate. Br. Med. J. 2, 419–421 (1975) Stevanovié, D. V.: Corticosteroid-induced atrophy of the skin with telangiectasia. A clinical and experimental study. Br. J. Dermatol. 87, 548–556 (1972) Stevanovic, D. V., Wilson, L., Sparkes, C. G.: A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate. Br. J. Dermatol. 96, 67–70 (1977) Stoughton, R. B.: Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison. Arch. Dermatol. 99, 753–756 (1969) Stüttgen, G.: Vasoconstriction in response to corticosteroids observed in human lips. Dermatologica 152, Suppl. 1, 91–100 (1976) Symons, A. M., Lewis, D. A., Ancill, R. J.: The actions of anti-inflammatory steroids on isolated rat liver mitochondrial function. J. Steroid Biochem. 5, 639–644 (1974) Tree, S., Marks, R.: An explanation for the ‘placebo” effect of bland ointment bases. Br. J. Dermatol. 92, 195–198 (1975) Voorhees, J. J., Marcelo, C. L., Duell, E. A.: Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J. Invest. Dermatol. 65, 179–190 (1975) Walker, S. R., Wilson, L., Fry, L., James, V. H. T.: The effect on plasma corticosteroid levels of the short-term topical application of clobetasol propionate. Br. J. Dermatol. 91, 339–343 (1974) Winter, G. D., Burton, J. L.: Experimentally induced steroid atrophy in the domestic pig and man. Br. J. Dermatol. 94, Suppl. 12, 107–109 (1976) Winter, G. D., Wilson, L.: The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig. Br. J. Dermatol. 94, 545–550 (1976) Winter, G. D., Wilson, L.: Corticosteroid induced atrophy in the skin of the domestic pig. In: Mechanisms of topical corticosteroud therapy, Wilson, L., Marks, R. (eds.), Chap. 10, pp. 77–88. London: Churchill Livingstone 1976a Wrench, R.: The isolation, production and development of dermatologically active constituents in coal tar. Ph. D. Thesis. Aston University (1973) Wrench, R.: Scale prophylaxis: A New antiparakeratotic assay. (in preparation) (1979) Wrench, R., Britten, A. Z.: Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. Part I: High and low temperature tars and their constituents. Br. J. Dermatol. 92, 569–574 (1975)